Free Trial
NASDAQ:RPID

Rapid Micro Biosystems Q3 2026 Earnings Date & Estimates

Rapid Micro Biosystems logo
$0.64 -0.03 (-4.62%)
As of 12:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Rapid Micro Biosystems is estimated to report Q3 2026 earnings on Friday, November 13, 2026, before market opens.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens

What Analysts Expect from Rapid Micro Biosystems in Q3 2026

Rapid Micro Biosystems is expected to post earnings of -$0.20 per share on revenue of $10 million. In the same quarter a year earlier Rapid Micro Biosystems reported -$0.26 per share on revenue of $7.84 million. Rapid Micro Biosystems last reported on August 7, 2026, posting -$0.27 per share and missing the -$0.2433 consensus estimate. Rapid Micro Biosystems has beaten the consensus EPS estimate in 1 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.20
Expected Revenue
$10 million
Prior-Year EPS
-$0.26
Prior-Year Revenue
$7.84 million
Expected Revenue Growth
+27.6%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.27 (Missed by -$0.0267)
Last Quarter Revenue
$8.05 million
EPS Beat Rate
1 of last 8 quarters

Rapid Micro Biosystems Q3 2026 Earnings FAQ

Rapid Micro Biosystems (NASDAQ:RPID) is estimated to report Q3 2026 earnings on Friday, November 13, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Rapid Micro Biosystems' Q3 2026 earnings conference call is scheduled for Friday, November 20, 2026 at 8:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Rapid Micro Biosystems to post earnings of -$0.20 per share for Q3 2026.

The consensus revenue estimate for Rapid Micro Biosystems is $10 million for Q3 2026.

Rapid Micro Biosystems Earnings Headlines

Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
See More Rapid Micro Biosystems Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rapid Micro Biosystems? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rapid Micro Biosystems and other key companies, straight to your email.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ:RPID) develops automated solutions for microbial quality control in regulated manufacturing environments. Its systems are designed to detect and quantify microorganisms more efficiently than traditional manual methods, helping customers improve testing workflows, data integrity, and laboratory productivity.

The company’s primary platform, Growth Direct, supports applications including environmental monitoring and rapid microbial testing. The platform combines automated incubation, imaging, detection, and reporting with dedicated consumables, enabling pharmaceutical, biotechnology, medical device, and other manufacturers to monitor contamination risks and evaluate product sterility.

Founded in 2006 and headquartered in Lowell, Massachusetts, Rapid Micro Biosystems serves customers in the pharmaceutical and biotechnology industries, as well as other regulated markets such as medical devices and personal care. The company’s products are marketed internationally and are intended to support the modernization of quality-control laboratories and the adoption of more automated manufacturing processes.

View Rapid Micro Biosystems Profile